Other studies and our previous article recently reported that a higher number of CD68-positive macrophages in biopsy specimens significantly predicted clinical progression of HF due to DCM in patients after a 1-year follow-up [5,6]. The gene discussed is CD68; the disease is familial dilated cardiomyopathy.